PTN - Palatin spikes as FDA clears mid-stage trial for weight loss therapy
2024-05-02 15:10:06 ET
More on Eli Lilly, Palatin Tech, etc.
- Eli Lilly Shoots Higher: It's Time To Be Cautious
- Eli Lilly: The GLP-1 Wonder Continues, A Bullish Beat And Raise
- Eli Lilly: Management Raises 2024 Guidance, Driven By GLP-1 Franchise
- GLP-1 drug prices falling at UK pharmacies, clinics: report
- Eli Lilly raises guidance on weight loss momentum